AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$1.21B |
| 2 |
Advanced Micro Devices
AMD
|
+$1.15B |
| 3 |
Quanta Services
PWR
|
+$691M |
| 4 |
Trane Technologies
TT
|
+$684M |
| 5 |
RTX Corp
RTX
|
+$655M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.74B |
| 2 |
Microsoft
MSFT
|
+$2.35B |
| 3 |
Broadcom
AVGO
|
+$744M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$636M |
| 5 |
TSMC
TSM
|
+$590M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.92% |
| 2 | Miscellaneous | 10.92% |
| 3 | Healthcare | 10.85% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Financials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2251
Tandem Diabetes Care
TNDM
$1.21B
| $1.34M | ﹤0.01% |
70,049
-3,100
| -4% | -$54.1K |
2018 Q2
32 quarters
|
|
2252
Matrix Service
MTRX
$275M
| $1.33M | ﹤0.01% |
116,280
+2,540
| +2% | +$32.7K |
2025 Q1
5 quarters
|
|
2253
MillerKnoll
MLKN
$1.45B
| $1.33M | ﹤0.01% |
92,106
+13,001
| +16% | +$208K |
2013 Q2
52 quarters
|
|
2254
NextDecade
NEXT
$1.67B
| $1.33M | ﹤0.01% |
173,820
+8,000
| +5% | +$63.3K |
2022 Q2
16 quarters
|
|
2255
Matthews International
MATW
$601M
| $1.33M | ﹤0.01% |
51,366
| – | – |
2013 Q2
52 quarters
|
|
2256
Corvus Pharmaceuticals
CRVS
$886M
| $1.32M | ﹤0.01% |
90,420
+28,680
| +46% | +$398K |
2025 Q2
4 quarters
|
|
2257
Ouster
OUST
$2.14B
| $1.32M | ﹤0.01% |
71,908
+21,103
| +42% | +$710K |
2024 Q2
8 quarters
|
|
2258
Lindsay Corp
LNN
$1.07B
| $1.32M | ﹤0.01% |
11,078
-132
| -1% | -$14.8K |
2013 Q2
52 quarters
|
|
2259
Innovex International
INVX
$2.09B
| $1.31M | ﹤0.01% |
53,884
+8,615
| +19% | +$234K |
2013 Q2
52 quarters
|
|
2260
Phibro Animal Health
PAHC
$1.58B
| $1.31M | ﹤0.01% |
23,720
-48,962
| -67% | -$2.07M |
2014 Q2
48 quarters
|
|
2261
SFL Corp
SFL
$1.76B
| $1.31M | ﹤0.01% |
121,563
| – | – |
2013 Q2
52 quarters
|
|
2262
Red Cat Holdings
RCAT
$677M
| $1.31M | ﹤0.01% |
99,930
| – | – |
2025 Q2
4 quarters
|
|
2263
Novavax
NVAX
$1.6B
| $1.31M | ﹤0.01% |
160,603
-2,610
| -2% | -$23.4K |
2013 Q2
52 quarters
|
|
2264
PC Connection
CNXN
$2.24B
| $1.31M | ﹤0.01% |
22,357
-37
| -0.2% | -$2.47K |
2017 Q2
36 quarters
|
|
2265
Dauch Corp
DCH
$1.1B
| $1.3M | ﹤0.01% |
219,665
-240,200
| -52% | -$1.46M |
2013 Q2
52 quarters
|
|
2266
Slide Insurance Holdings
SLDE
$3.33B
| $1.3M | ﹤0.01% |
72,100
| – | – |
2026 Q1
1 quarter
|
|
2267
Upbound Group
UPBD
$996M
| $1.29M | ﹤0.01% |
71,528
-900
| -1% | -$16.8K |
2013 Q2
52 quarters
|
|
2268
Nordic American Tanker
NAT
$1.66B
| $1.29M | ﹤0.01% |
220,101
| – | – |
2013 Q2
52 quarters
|
|
2269
GeneDx Holdings
WGS
$1.67B
| $1.29M | ﹤0.01% |
20,050
| – | – |
2024 Q2
8 quarters
|
|
2270
QuidelOrtho
QDEL
$942M
| $1.28M | ﹤0.01% |
78,143
-2,700
| -3% | -$35.7K |
2013 Q2
52 quarters
|
|
2271
Galaxy Digital Inc
GLXY
$2.85B
| $1.28M | ﹤0.01% |
+69,369
| New | +$1.93M |
2026 Q2
0 quarters
|
|
2272
RLJ Lodging Trust
RLJ
$1.84B
| $1.28M | ﹤0.01% |
172,452
+11,459
| +7% | +$107K |
2013 Q2
52 quarters
|
|
2273
Credit Acceptance
CACC
$5.66B
| $1.28M | ﹤0.01% |
3,021
+1,319
| +77% | +$706K |
2013 Q2
52 quarters
|
|
2274
Chimera Investment
CIM
$705M
| $1.28M | ﹤0.01% |
101,855
+40,900
| +67% | +$548K |
2013 Q2
52 quarters
|
|
2275
FIGS
FIGS
$3.36B
| $1.27M | ﹤0.01% |
86,306
-12,000
| -12% | -$158K |
2021 Q2
20 quarters
|
|
Similar funds
AllianceBernstein's Q2 2026 Portfolio in Review
As of Q2 2026, AllianceBernstein held 3,456 positions worth $302B, down 2.1% from $309B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
AllianceBernstein withdrew a net $10.1B in Q2 2026, closing 139 positions and reducing 1,179 holdings. Its most notable exit was Hologic, an estimated $75.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Miscellaneous and Healthcare.
Against the trend, AllianceBernstein opened a new position in Honeywell Aerospace worth $183M.
- AllianceBernstein's largest Q2 2026 buy was Honeywell Aerospace: 827,059 shares worth $183M.
- AllianceBernstein added most to Micron Technology in Q2 2026, an estimated $1.21B increase.
- AllianceBernstein's biggest Q2 2026 reduction was Amazon, cutting an estimated $3.74B.
- AllianceBernstein fully exited Hologic in Q2 2026, selling an estimated $75.9M.
- AllianceBernstein's ten largest holdings make up 31% of its $302B portfolio in Q2 2026.
- AllianceBernstein opened 228 new positions and closed 139 in Q2 2026.
- AllianceBernstein's portfolio value fell 2.1% quarter-over-quarter to $302B.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.